Our Team

GENERAL Management &
SCientific team
Picture 1.jpg

Chairman

XiangQIAN (XQ) LIN

Wharton-educated seasoned innovator, entrepreneur, and investor who is the Chairman and Founding Managing Director of EVX Ventures, Group President & CEO of Esco group, as well as co-founder of multiple biotech startups, including PairX Bio and Carmine Therapeutics.

RKP.png

Vice-President, Chemistry

Rajendra Pandey,PHD

A pioneer in nucleic acid therapeutics at Alnylam Pharmaceuticals and held senior leadership positions at prominent pharmaceutical companies including Aligos Therapeutics, Janssen Pharmaceuticals and Spring Bank Pharmaceuticals. Co-author of 27 scientific publications and co-inventor on 22 issued or pending patents.

Picture 7.jpg

Senior Director, Biology

Si hui tan,PHD

Stanford-educated cancer biologist with publications in Nature and Science and more than 10 years’ research experience in cancer, stem cell and regeneration. In recognition of her outstanding research, she was awarded several grants and the President’s Young Scientist Award.

Caiyun Deng.jpeg

Director, Preclinical Development

Caiyun Deng,PHD

Preclinical development specialist with experience in preclinical development and IND application for various therapeutic modalities including monoclonal antibodies, small molecules, and small nucleic acids. Recipient of multiple competitive research grants and co-author on several international peer-reviewed research articles.

2d9c34f14b9397db5bdd5cf162972024.jpg

Chief Executive Officer

Kathy He

Seasoned and insightful biopharmaceutical industry executive with over 20 years of experience in helping to grow multiple global companies, leading many successful strategic collaborations and fundraising events. Extensive US and China cross-border business leadership experience in start-ups and MNCs, including at Kira Pharmaceuticals, Abbisko Therapeutics, Takeda Pharmaceuticals, Merck & Co. and Abbott Labs.

1562691353572.jpeg.jpg

Senior Advisor

Sergei m. gryaznov,PHD

A leader in nucleic acid therapeutics who held key leadership roles in Janssen Pharma (part of Johnson and Johnson family of companies), Geron Corporation and MAIA Bio-technology. Co-author of more than 120 scientific publications and co-inventor on more than 50 issued or pending patents.

sissi.jpg

Director, Chemistry

Sissi lin,PHD

US-trained organic chemist with extensive research experience in nucleic acid chemistry and biomedical application of nucleic acids. Co-author of multiple scientific publications and co-inventor on several patents.

Eileen.jpeg

Senior Director, Finance

Eileen Wang

Financial and accounting expert with more than 15 years of experience in the corporate financing arena, with responsibilities ranging from auditing and internal control, to corporate fundraising and M&A deals, while working in multinational as well as private companies.

Picture 2.jpg

Chief Scientific Officer

Yann Chong Tan,Phd

Stanford-educated serial entrepreneur and a successful inventor with extensive experience in the biotech space, who co-founded and held senior leadership roles in Atreca, a Nasdaq-listed biotech, and Nuevocor.

img_9795.jpg

Director, Research

binxia yang,PHD

MD/PhD scientist with more than 10 years of experience in iPSC and translational regenerative medicine. Co-author of 15 scientific publications and co-developer of multiple technologies and therapies related to eye disease and oncology.

20191012_174128_IMG_7438.jpg

Associate Director, Operations and Project Management

Marcus tan,PHD

Harvard-educated life science and medtech/biotech professional with more than 15 years’ experience in biological research, technology scouting as well as product and clinical management. Co-author of multiple scientific publications.

Chairman

XiangQIAN (XQ) LIN

Wharton-educated seasoned innovator, entrepreneur, and investor who is the Chairman and Founding Managing Director of EVX Ventures, Group President & CEO of Esco group, as well as co-founder of multiple biotech startups, including PairX Bio and Carmine Therapeutics.

SCIENTIFIC
ADVISORY BOARD
Picture 10.jpg

Scientific Advisor

Professor Harvey Lodish

Founding Member of the Whitehead Institute for Biomedical Research, as well as Professor of Biology and a Professor of Biological Engineering at the Massachusetts Institute of Technology (MIT). Elected into the US National Academy of Sciences.

20211110_125107.jpg

Scientific Advisor

Torsten wuestefeld,phd

Seasoned scientist with over 2 decades of target discovery experience for liver diseases. Principal Investigator at Genome Institute of Singapore (GIS, A*STAR)

Picture 12.png

Scientific Advisor

Professor Roger foo

Senior Consultant at the National University Heart Centre, National University Hospital System (NUHS) and Professor of Medicine at the National University Singapore Yong Loo Lin School of Medicine. Director of the NUHS Cardio-vascular Disease Translational Research Programme.

Picture 13.png

Scientific Advisor

Professor Kosh ray

Honorary Consultant Cardiologist at the Imperial College NHS Trust and Professor of Public Health in the Department of Public Health and Primary Care at the Imperial College London. President of the European Atherosclerosis Society, as well as Fellow and member of prestigious medical and scientific societies, including the European Society of Cardiology and Royal College of Physicians.